The Goldman Sachs Group, Inc. (<a rel="nofollow" class="qLink" href="#" OnClick="singleQuoteDialog('GS'); return false;">GS</a>) 13D/13G Filings for Kiora Pharmaceuticals, Inc. (<a rel="nofollow" class="qLink" href="#" OnClick="singleQuoteDialog('KPRX'); return false;">KPRX</a>)

The Goldman Sachs Group, Inc. 13D and 13G filings for Kiora Pharmaceuticals, Inc.:

Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
Shares have been adjusted for stock splits.

Reported DateTime	Transaction Date	Type	Company Symbol	Filed By Symbol	Shares Owned % Owned	Shares Vs. Prev Report	View
2025-02-12 11:39 am Sale	2024-12-31	13G	Kiora Pharmaceuticals, Inc. KPRX	GOLDMAN SACHS GROUP INC GS	130 0.000%	-180,662 (-99.93%)	Filing
2024-11-12 5:58 pm Purchase	2024-09-30	13G	Kiora Pharmaceuticals, Inc. KPRX	GOLDMAN SACHS GROUP INC GS	180,792 6.100%	180,792 (New Position)	Filing

The Goldman Sachs Group, Inc. (GS) 13D/13G Filings for Kiora Pharmaceuticals, Inc. (KPRX)